Attached files
file | filename |
---|---|
8-K - FORM 8-K - CYBEX INTERNATIONAL INC | d8k.htm |
Exhibit 99.1
COMPANY | Arthur W. Hicks, Jr. | |
CONTACT: | President and COO | |
(508) 533-4300 |
FOR IMMEDIATE RELEASE
CYBEX ANNOUNCES THIRD QUARTER RESULTS
MEDWAY, MA, October 20, 2009 Cybex International, Inc. (NASDAQ: CYBI), a leading manufacturer of premium exercise equipment for the commercial and consumer markets, today reported results for its third quarter ended September 26, 2009.
Net sales for the third quarter of 2009 were $29.0 million compared to $35.8 million for the corresponding 2008 period. The Company reported net income for the third quarter of 2009 of $0.1 million, or $0.00 per diluted share, compared to $0.3 million, or $0.02 per diluted share, reported for the corresponding 2008 period.
For the nine months ended September 26, 2009, net sales decreased to $85.7 million compared to $108.7 million for 2008. The loss for the nine months ended September 26, 2009 was $3.4 million, or $0.20 per diluted share, compared to net income of $1.8 million, or $0.10 per diluted share, for 2008.
John Aglialoro, Chairman and CEO stated, During the past year, CYBEX has focused on broadening into additional market segments as the health club market has remained stagnant. This has included not only new product positioning, but broader marketing and sales approaches which I believe will position CYBEX well for 2010. In the meantime, I appreciate the efforts our employees have made this year and commend our managers for balancing cost reductions with investments needed to promote the long-term success of CYBEX.
Arthur Hicks, President and CFO stated, During the quarter, we renegotiated our financial covenants with our banks. We were in compliance with these financial covenants as of the end of the quarter, and expect to remain in compliance for the foreseeable future.
The Company will hold a conference call today at 4:30 p.m. If you cannot participate in the call but wish to listen to it, you may login at CYBEXs website at www.cybexintl.com. Under the category Company, click on Press, scroll to bottom and select Q3 Earnings Release Conference Call.
-more-
-2-
About CYBEX
Cybex International, Inc. is a leading manufacturer of premium exercise equipment for commercial and consumer use. The CYBEX product line, including a full range of strength and cardio training machines, is designed using exercise science to reflect the natural movement of the human body. Led by the Cybex Institute for Exercise Science, CYBEX fitness equipment is engineered to produce optimal results for users from the first-time exerciser to the professional athlete. Products are available for a wide range of facilities, from commercial health clubs to home gyms, and are sold in more than 85 countries worldwide. For more information on CYBEX and its product lines, visit the Companys website at www.cybexintl.com.
This news release may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, competitive factors, technological and product developments, market demand, economic conditions, the resolution of litigation involving the Company, and the ability of the Company to comply with the terms of its credit facilities. Further information on these and other factors which could affect the Companys financial results can be found in the Companys previously filed Report on Form 10-K for the year ended December 31, 2008, its Reports on Form 10-Q, its Current Reports on Form 8-K, and its proxy statement dated March 26, 2009.
- Financial Tables to Follow -
-3-
CYBEX INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(unaudited)
Three Months Ended | Nine Months Ended | |||||||||||||||
September 26, 2009 |
September 27, 2008 |
September 26, 2009 |
September 27, 2008 |
|||||||||||||
Net sales |
$ | 28,986 | $ | 35,753 | $ | 85,662 | $ | 108,669 | ||||||||
Cost of sales |
19,829 | 24,202 | 61,461 | 72,290 | ||||||||||||
Gross profit |
9,157 | 11,551 | 24,201 | 36,379 | ||||||||||||
As a percentage of sales |
31.6 | % | 32.3 | % | 28.3 | % | 33.5 | % | ||||||||
Selling, general and administrative expenses |
8,997 | 10,600 | 27,932 | 32,240 | ||||||||||||
Operating income (loss) |
160 | 951 | (3,731 | ) | 4,139 | |||||||||||
Interest expense, net |
307 | 306 | 907 | 931 | ||||||||||||
Income (loss) before income taxes |
(147 | ) | 645 | (4,638 | ) | 3,208 | ||||||||||
Income taxes (benefit) |
(228 | ) | 305 | (1,208 | ) | 1,422 | ||||||||||
Net income (loss) |
$ | 81 | $ | 340 | $ | (3,430 | ) | $ | 1,786 | |||||||
Basic net income per share |
$ | 0.00 | $ | 0.02 | $ | (0.20 | ) | $ | 0.10 | |||||||
Diluted net income per share |
$ | 0.00 | $ | 0.02 | $ | (0.20 | ) | $ | 0.10 | |||||||
Shares used in computing basic net income per share |
17,096 | 17,560 | 17,201 | 17,439 | ||||||||||||
Shares used in computing diluted net income per share |
17,096 | 17,660 | 17,201 | 17,566 | ||||||||||||
-more-
-4-
CYBEX INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(unaudited)
September 26, 2009 |
December 31, 2008 | |||||
ASSETS |
||||||
Current assets: |
||||||
Cash and cash equivalents |
$ | 1,169 | $ | 1,628 | ||
Accounts receivable, net |
17,449 | 18,735 | ||||
Inventories |
12,502 | 13,465 | ||||
Prepaid expenses and other |
1,358 | 2,249 | ||||
Deferred tax asset |
4,685 | 4,685 | ||||
Total current assets |
37,163 | 40,762 | ||||
Property and equipment, net |
32,759 | 36,551 | ||||
Deferred tax asset |
9,735 | 8,698 | ||||
Other assets |
4,949 | 5,290 | ||||
$ | 84,606 | $ | 91,301 | |||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||
Current liabilities: |
||||||
Current maturities of long-term debt |
$ | 2,915 | $ | 1,882 | ||
Accounts payable |
4,324 | 5,965 | ||||
Accrued expenses |
11,087 | 11,986 | ||||
Total current liabilities |
18,326 | 19,833 | ||||
Long-term debt |
15,920 | 16,606 | ||||
Other liabilities |
8,477 | 9,411 | ||||
Total liabilities |
42,723 | 45,850 | ||||
Stockholders equity |
41,883 | 45,451 | ||||
$ | 84,606 | $ | 91,301 | |||
#####